IDH1 and intrahepatic cholangiocarcinoma: In this study, we employed a panel of small molecular drug screening to search for potential cluster-specific dependencies of ICC cell lines, and several potential therapeutic targets were identified in Cluster2A (IDH1 mutant) ICC cell lines.